What is the optimal reduced‐intensity conditioning regimen for patients with classical Hodgkin lymphoma undergoing allogeneic transplantation? – is there a one to use or avoid

A majority of patients with classical Hodgkin lymphoma (cHL) will achieve remission with frontline treatment and have long-term disease control. However, approximately 10–15% of early-stage (favourable)1-3 and 15–30% of advanced-stage cHL4-6 will relapse after frontline treatment. For patients with relapsed/refractory cHL, treatment with salvage chemotherapy followed by autologous haematopoietic cell transplantation (auto-HCT) is potentially...